6,071 followers
RT @I2BHouston: Low dose metronomic oral cyclophosphamide for hormone resistant prostate cancer: a phase II study. - PubMed - NCBI https://…
RT @I2BHouston: Low dose metronomic oral cyclophosphamide for hormone resistant prostate cancer: a phase II study. - PubMed - NCBI https://…
Low dose metronomic oral cyclophosphamide for hormone resistant prostate cancer: a phase II study. - PubMed - NCBI https://t.co/F7wee35aDe